(Q39460894)

12 September 2017

1 reference

title

Pharmacotherapy of Raynaud's phenomenon (English)

1 reference

12 September 2017

0 references

J J Belch

1

1 reference

12 September 2017

M Ho

series ordinal

2

1 reference

12 September 2017

1 November 1996

1 reference

12 September 2017

1 reference

12 September 2017

52

1 reference

12 September 2017

5

1 reference

12 September 2017

682-695

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199652050-00006

12 September 2017

0 references

cites work

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

1 reference

12 December 2020

Current and potential therapeutic effects of pentoxifylline.

1 reference

12 December 2020

Controlled trial of nifedipine in the treatment of Raynaud's phenomenon

1 reference

12 December 2020

Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon

1 reference

12 December 2020

Hexopal in Raynaud's Disease

1 reference

12 December 2020

An epidemiological survey of Raynaud's phenomenon

1 reference

12 December 2020

Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire

1 reference

12 December 2020

Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome.

1 reference

12 December 2020

Oral limaprost for Raynaud's phenomenon

1 reference

12 December 2020

A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon

1 reference

12 December 2020

Psoriatic arthritis with dyspnoea

1 reference

12 December 2020

White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome

1 reference

12 December 2020

Effect of lymphotoxin and tumor necrosis factor on endothelial and connective tissue cell growth and function

1 reference

12 December 2020

Prevalence of primary Raynaud phenomena in young females

1 reference

12 December 2020

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting

1 reference

12 December 2020

The acute effects of cigarette smoking on cutaneous blood flow in smoking and non-smoking subjects with and without Raynaud's phenomenon

1 reference

12 December 2020

Treatment of Raynaud's phenomenon with calcium channel blockers

1 reference

12 December 2020

Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon)

1 reference

12 December 2020

Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin

1 reference

12 December 2020

Clinical and rheological effects of nifedipine in Raynaud's phenomenon

1 reference

12 December 2020

A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease

1 reference

12 December 2020

Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial

1 reference

12 December 2020

Evaluation and management of patients with Raynaud's syndrome

1 reference

12 December 2020

INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROME

1 reference

12 December 2020

Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease

1 reference

12 December 2020

The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: a single-blind dose-response study

1 reference

12 December 2020

Quantitative thermal imaging to assess inositol nicotinate treatment for Raynaud's syndrome

1 reference

12 December 2020

DECREASED OESOPHAGEAL BLOOD FLOW IN PATIENTS WITH RAYNAUD'S PHENOMENON

1 reference

12 December 2020

Medical treatment in Raynaud's disease

1 reference

12 December 2020

The efficacy of thymoxamine in primary Raynaud's phenomenon

1 reference

12 December 2020

Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's Phenomenon

1 reference

12 December 2020

The clinical significance of Raynaud's syndrome

1 reference

12 December 2020

Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.

1 reference

12 December 2020

Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome

1 reference

12 December 2020

International study of ketanserin in Raynaud's phenomenon

1 reference

12 December 2020

Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis

1 reference

12 December 2020

The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study

1 reference

12 December 2020

Prevention of predictable Raynaud's phenomenon by sublingual nifedipine

1 reference

12 December 2020

Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon

1 reference

12 December 2020

Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's disease

1 reference

12 December 2020

A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

1 reference

12 December 2020

Capillary abnormalities in polyvinyl chloride production workers. Examination by in vivo microscopy

1 reference

12 December 2020

Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon

1 reference

12 December 2020

An Experimentally Controlled Evaluation of the Effect of Inositol Nicotinate upon the Digital Blood Flow in Patients with Raynaud's Phenomenon

1 reference

12 December 2020

Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study

1 reference

12 December 2020

The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers

1 reference

12 December 2020

Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

1 reference

12 December 2020

Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study

1 reference

12 December 2020

The importance of presynaptic beta receptors in Raynaud's disease

1 reference

12 December 2020

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases

1 reference

12 December 2020

Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation

1 reference

12 December 2020

Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial

1 reference

12 December 2020

Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis

1 reference

12 December 2020

Thymoxamine for Raynaud's disease and chilblains

1 reference

12 December 2020

Abnormal biochemical and cellular parameters in the blood of patients with Raynauds phenomenon

1 reference

12 December 2020

Vascular damage and factor-VIII-related antigen in the rheumatic diseases

1 reference

12 December 2020

The treatment of severe Raynaud's phenomenon with verapamil

1 reference

12 December 2020

Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study

1 reference

12 December 2020

Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon

1 reference

12 December 2020

Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon.

1 reference

12 December 2020

A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon

1 reference

12 December 2020

10.2165/00003495-199652050-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1048462398

0 references

Fatcat ID

release_na2i3tdovfe7hgx4mvscjzarvi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/na2i3tdovfe7hgx4mvscjzarvi

24 November 2022

mapped directly with Wikidata item

1 reference